2003
DOI: 10.1039/b300554b
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and reactions of a novel 3,4-didehydropyroglutamate derivative

Abstract: Some reactions such as catalytic hydrogenation, Diels-Alder reaction, cyclopropanation, dihydroxylation, and Michael addition of a novel 3,4-didehydropyroglutamate derivative, in which the carboxylic group is protected as an ABO ester, are examined and found to take place in a stereospecific manner giving 3- and/or 4-substituted pyroglutamate derivatives without loss of enantiomeric purity at the alpha-position.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…100 The N-tert-butoxycarbonyl-protected dimethyl ester of L-CCG-III (2R,2′S,2′S)-99 was also synthesized as an intermediate en route to (S)-endo-3,4-methano-L-proline [(S)-endo-84] (see section 2.6, Scheme 14), which was converted into its fully deprotected form (2R,2′S,2′S)-127 by acid hydrolysis. 63,101 The cyclopropanation of the enantiopure 3,4-didehydro-4-pyroglutamine orthoester 95 with tert-butyl dimethylsulfuranylideneacetate provided the 3-aza-4-oxabicyclo[3.1.0]hexanedicarboxylic acid derivative 174 as a separable mixture of the two diastereomers exo,endo-174 and exo,exo-174. Chemoselective ring opening of the lactam in 174, subsequent Barton decarboxylation, and final hydrolysis gave rise to L-CCG-IV (2S,1′R,2′S)-127 starting from exo,endo-174 and L-CCG-II (2S,1′R,2′R)-127 from exo,exo-174, repectively (Scheme 29).…”
Section: 4-methanoprolinementioning
confidence: 99%
See 2 more Smart Citations
“…100 The N-tert-butoxycarbonyl-protected dimethyl ester of L-CCG-III (2R,2′S,2′S)-99 was also synthesized as an intermediate en route to (S)-endo-3,4-methano-L-proline [(S)-endo-84] (see section 2.6, Scheme 14), which was converted into its fully deprotected form (2R,2′S,2′S)-127 by acid hydrolysis. 63,101 The cyclopropanation of the enantiopure 3,4-didehydro-4-pyroglutamine orthoester 95 with tert-butyl dimethylsulfuranylideneacetate provided the 3-aza-4-oxabicyclo[3.1.0]hexanedicarboxylic acid derivative 174 as a separable mixture of the two diastereomers exo,endo-174 and exo,exo-174. Chemoselective ring opening of the lactam in 174, subsequent Barton decarboxylation, and final hydrolysis gave rise to L-CCG-IV (2S,1′R,2′S)-127 starting from exo,endo-174 and L-CCG-II (2S,1′R,2′R)-127 from exo,exo-174, repectively (Scheme 29).…”
Section: 4-methanoprolinementioning
confidence: 99%
“…Chemoselective ring opening of the lactam in 174, subsequent Barton decarboxylation, and final hydrolysis gave rise to L-CCG-IV (2S,1′R,2′S)-127 starting from exo,endo-174 and L-CCG-II (2S,1′R,2′R)-127 from exo,exo-174, repectively (Scheme 29). 63,101 A Michael-induced ring closure (MIRC) reaction of the glycinate enolate generated from ethyl (diphenylmethyleneamino)acetate ( 176) with the enantiopure (-)-menthyl 4-bromocrotonate (175) furnished the cyclopropane derivative 177 as a single diastereomer. Successive acid-and base-catalyzed hydrolysis of the ester and Schiff-base functionalities led to enantiomerically pure L-CCG-I (2S,1′S,2′S)-127 (Scheme 30).…”
Section: 4-methanoprolinementioning
confidence: 99%
See 1 more Smart Citation
“…To illustrate this strategy dihydroxylation of the orthoester 92 (derived from L-pyroglutamic acid [97]) was performed to afford a single diastereoisomer 93 since the bulky orthoester residue allows the osmylation to occur from the opposite side (less hindered face). After purification of the diacetate 94 the recovery of acid (2 S ,3 R ,4 R )- 4 was performed (Scheme 24) [98]. However, the hydrolysis was carried out under mild conditions to prevent decomposition of this stereoisomer including racemization at Cα.…”
Section: Reviewmentioning
confidence: 99%
“…Oba et al published concomitantly the same approach to 3-methyl glutamic acid using an ABO protecting group and observed also an excellent diastereoselectivity in 1,4-addition on the pyroglutamic acid. 211…”
Section: Cycloadditionsmentioning
confidence: 99%